封面
市场调查报告书
商品编码
1659392

全球尿道结石管理设备市场

Urolithiasis Management Devices

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球尿道结石管理设备市场规模将达 28 亿美元

2024 年全球尿道结石管理设备市场规模估计为 20 亿美元,预计到 2030 年将达到 28 亿美元,2024-2030 年分析期间的复合年增长率为 5.5%。体外震波碎石术 (ESWL) 治疗是报告中分析的一个细分领域,预计其复合年增长率为 5.3%,到分析期结束时将达到 11 亿美元。在分析期内,体外碎石部分预计以 5.8% 的复合年增长率成长。

美国市场规模估计为 5.287 亿美元,而中国市场预计以 8.3% 的复合年增长率成长

预计 2024 年美国尿道结石管理设备市场价值将达到 5.287 亿美元。中国是世界第二大经济体,预计到 2030 年市场规模将达到 6.289 亿美元,2024-2030 年分析期间的复合年增长率为 8.3%。其他值得注意的区域市场包括日本和加拿大,预计在分析期间的复合年增长率分别为 3.3% 和 4.4%。在欧洲,德国的复合年增长率预计为 4.0%。

全球尿道结石管理设备市场 - 主要趋势与驱动因素摘要

什么是尿道结石管理装置?

尿道结石管理设备是一种用于诊断、管理和治疗尿道结石(包括肾臟、输尿管、膀胱和尿道)中形成结石的疾病的医疗设备。尿道结石,俗称肾结石,如果不及时治疗,会导致剧烈疼痛、闭尿症和肾臟损伤。这些设备包括多种技术,包括体外震波碎石术 (ESWL)、输尿管镜、肾镜、雷射碎石术和支架,旨在分解、去除或促进肾结石通过泌尿道。这些设备可进行非侵入性治疗和微创治疗,进而改善患者的治疗效果并缩短恢復时间。

尿道结石管理设备的重要性在于它们能够解决影响全球数百万人的常见健康问题。饮食习惯、脱水、肥胖和某些医疗状况等因素都会造成肾结石的形成,因此有效的管理对于维持肾臟健康至关重要。早期诊断和及时治疗对于预防感染疾病、肾衰竭和復发性结石等併发症至关重要。尿道结石管理设备为医疗保健专业人员提供了根据结石的大小、成分和位置制定治疗计划的工具,提供了以患者为中心的肾结石管理方法。随着全球尿道结石的发病率持续上升,这些设备在确保有效、安全和高效的治疗方面发挥着至关重要的作用。

科技进步如何影响尿道结石管理设备市场?

技术进步显着提高了尿道结石管理设备的准确性、有效性和安全性,推动了肾结石治疗的创新。最显着的进展之一是体外震波碎石术 (ESWL) 的改进。这是一种非侵入性技术,利用聚焦衝击波将肾结石分解成可以自然通过的小碎片。现代 ESWL 机器提供即时成像、改进的结石定位和患者定位功能,从而提高成功率、缩短治疗时间并增加患者的舒适度。此外,电磁和压电碎石机的进步提高了 ESWL 设备的精度和能量传输,提高了结石破碎的效率。

微创手术在输尿管镜和肾臟镜的设计、灵活性和影像处理能力方面取得了巨大进展。数位输尿管镜的发展提供了高清影像,提高了尿道结石的检测、定位和去除能力。微型柔性输尿管镜可以接触到难以触及的结石,同时最大限度地减少对周围组织的创伤并缩短恢復时间。雷射碎石术也随着创新而发展,例如使用提供高脉衝率、可调脉衝宽度和双波长技术的钬雷射系统。这些进步使得结石破碎更加有效,特别是对于较硬或较大的结石,并且可以更好地控製手术过程,并提高安全性。

另一个重要进展是使用机器人辅助手术器械来治疗复杂的肾结石切除病例。机器人技术提供了更高的精确度、控制力和灵活性,以改善经皮肾结石 (PCNL) 和其他侵入性手术的结果。此外,改进的支架设计,如药物释放型和生物分解性支架,可以帮助术后护理管理并减少输尿管阻塞和感染疾病等併发症。这些创新不仅扩展了尿道结石管理设备的功能,而且符合更广泛的趋势,即微创、对病人友善的治疗方法,可减少住院时间和医疗费用。

尿道结石管理设备在医疗保健领域有哪些新兴应用?

由于肾结石发病率的不断上升和治疗方法的进步,尿道结石管理设备被广泛应用于各种医疗保健领域。它们广泛用于医院和专科泌尿系统中心的诊断和治疗目的,支持 ESWL、输尿管镜检查和经皮肾镜碎石术 (PCNL) 等程序。泌尿系统依靠先进的成像和雷射系统来确保准确定位、有效破碎和彻底清除结石,改善患者的治疗效果并降低復发率。这些设备对于门诊手术中心也很重要,因为门诊手术中心通常会采用微创手术来治疗小结石,以便患者当天出院并更快地康復。

在急救环境中,掌上超音波诊断设备和可携式影像工具对于快速诊断和评估急性尿道结石例至关重要,可以快速决策适当的治疗方法。远端医疗平台还整合了远距咨询和诊断功能,用于初步评估和后续护理,支援更广泛地获得尿道结石管理。在初级保健和诊所,超音波和先进的尿液分析套件等非侵入性诊断工具可用于早期发现结石形成,以便及时转诊给专科医生并减少紧急干预的需要。此外,在居家医疗环境中,穿戴式感测器和数位健康应用程式被用于监测水分、饮食摄取量和潜在的结石症状,帮助患者主动管理尿道结石。随着医疗保健变得更加分散和以患者为中心,尿道结石管理设备的应用范围正在不断扩大,反映了它们在不同护理环境中满足不同医疗保健需求的多功能性。

推动尿道结石管理设备市场成长的因素是什么?

尿道结石管理设备市场的成长受到多种因素的推动,例如肾结石盛行率的上升、微创治疗的采用率的提高以及诊断和治疗技术的进步。其中一个主要成长要素是全球尿道结石例的增加,这是由生活方式因素造成的,例如缺水、高钠饮食、肥胖以及糖尿病和高血压等代谢疾病。随着肾结石发病率的增加,对有效、及时的管理解决方案的需求急剧上升,使得尿道结石管理设备成为医疗保健提供者必不可少的工具。由于患者和医疗保健提供者更喜欢恢復更快、疼痛更少、併发症率更低的治疗,人们对体外震波碎石术、输尿管镜检查和雷射碎石术等微创手术的认识不断提高,推动了这些设备的进一步应用。

成像和雷射技术的进步也在市场成长中发挥关键作用。高清数位输尿管镜、先进的碎石机和人工智慧诊断工具的发展提高了肾结石治疗的准确性、安全性和效率,从而改善了患者的治疗效果。此外,人工智慧和机器学习在成像和诊断领域的整合正在增强结石的检测、表征和治疗计划,使尿道结石管理更加精准和个性化。政府措施和医疗政策促进了更好的泌尿系统治疗、增加了医疗保健的机会以及开展了有关预防和管理肾结石的宣传活动,进一步支持了市场的成长。

门诊手术中心和门诊诊所的增加也促进了尿道结石管理设备市场的成长。这些设施提供经济高效的护理,并增加了患者接受微创手术的机会。随着远距远端医疗和远端监控、饮食建议和治疗后护理的数位健康工具的扩展,尿道结石管理变得更加全面,支持患者主动管理病情。随着医疗保健系统继续优先考虑以患者为中心的护理和先进的医疗技术,治疗的创新、医疗意识的增强以及全球对改善泌尿系统结果的关注预计将推动对尿道结石管理设备的需求。

部分

治疗类型(ESWL、腔内碎石术、经皮肾镜碎石术、其他治疗类型);最终用途(医院/诊所、门诊手术中心)

受访公司范例(总合42家公司)

  • Boston Scientific Corporation
  • Cook Medical, LLC
  • Dornier MedTech GmbH
  • Gimmi GmbH
  • KARL STORZ SE & Co. KG
  • Olympus America
  • Olympus Europa SE & Co. KG
  • Richard Wolf GmbH
  • Storz Medical AG
  • Walz Elektronik GmbH

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲国家
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP23002

Global Urolithiasis Management Devices Market to Reach US$2.8 Billion by 2030

The global market for Urolithiasis Management Devices estimated at US$2.0 Billion in the year 2024, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Extracorporeal Shock Wave Lithotripsy (ESWL) Treatment, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Intracorporeal Lithotripsy Treatment segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$528.7 Million While China is Forecast to Grow at 8.3% CAGR

The Urolithiasis Management Devices market in the U.S. is estimated at US$528.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$628.9 Million by the year 2030 trailing a CAGR of 8.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Urolithiasis Management Devices Market - Key Trends & Drivers Summarized

What Are Urolithiasis Management Devices, and Why Are They So Crucial in Treating Kidney Stones?

Urolithiasis Management Devices are medical tools and equipment used to diagnose, manage, and treat urolithiasis, which is the formation of stones in the urinary system, including the kidneys, ureters, bladder, and urethra. Urolithiasis, commonly known as kidney stones, can cause severe pain, urinary blockages, and potential kidney damage if left untreated. These devices encompass a range of technologies, including extracorporeal shock wave lithotripsy (ESWL) machines, ureteroscopes, nephroscopes, laser lithotripters, and stents, which are designed to break down, remove, or facilitate the passage of kidney stones from the urinary tract. The devices allow for both non-invasive and minimally invasive treatment options, improving patient outcomes and reducing recovery times.

The importance of urolithiasis management devices lies in their ability to address a prevalent health condition that affects millions of individuals worldwide. Factors like dietary habits, dehydration, obesity, and certain medical conditions contribute to the development of kidney stones, making effective management crucial for maintaining renal health. Early diagnosis and timely treatment are essential to prevent complications such as infection, renal failure, and recurrent stone formation. Urolithiasis management devices provide healthcare professionals with tools to tailor treatment plans based on stone size, composition, and location, offering a patient-centric approach to kidney stone management. As the incidence of urolithiasis continues to rise globally, these devices play a critical role in ensuring effective, safe, and efficient treatment.

How Are Technological Advancements Shaping the Urolithiasis Management Devices Market?

Technological advancements have significantly enhanced the precision, efficacy, and safety of Urolithiasis Management Devices, driving innovation in kidney stone treatment. One of the most notable developments is the improvement in Extracorporeal Shock Wave Lithotripsy (ESWL), a non-invasive technique that uses focused shock waves to break kidney stones into smaller fragments that can be passed naturally. Modern ESWL devices are equipped with real-time imaging, improved stone localization, and patient positioning features, leading to higher success rates, reduced treatment times, and greater patient comfort. Additionally, advancements in electromagnetic and piezoelectric lithotripters have increased the precision and energy delivery of ESWL devices, enhancing stone fragmentation efficiency.

In minimally invasive procedures, ureteroscopes and nephroscopes have seen significant advancements in design, flexibility, and imaging capabilities. The development of digital ureteroscopes, which offer high-definition visualization, has improved the detection, targeting, and removal of stones in the urinary tract. Miniaturized and flexible ureteroscopes enable access to difficult-to-reach stones while minimizing trauma to surrounding tissues, reducing recovery times. Laser lithotripsy has also evolved, with innovations such as the use of holmium laser systems that offer high pulse rates, adjustable pulse widths, and dual-wavelength technology. These advancements allow for more efficient stone fragmentation, particularly in harder or larger stones, and provide better control over the procedure, enhancing safety.

Another key advancement is in the use of robotic-assisted surgical tools for complex cases of kidney stone removal. Robotic technologies offer greater precision, control, and dexterity, improving outcomes in percutaneous nephrolithotomy (PCNL) and other invasive procedures. Additionally, improved stent designs, such as drug-eluting and biodegradable stents, help in managing post-operative care, reducing complications like ureteral obstruction and infection. These technological innovations not only expand the capabilities of urolithiasis management devices but also align with broader trends toward minimally invasive, patient-friendly treatments that reduce hospital stays and healthcare costs.

What Are the Emerging Applications of Urolithiasis Management Devices Across Different Healthcare Settings?

Urolithiasis Management Devices are finding expanding applications across various healthcare settings, driven by the increasing prevalence of kidney stones and advancements in treatment modalities. In hospitals and specialized urology centers, these devices are widely used for both diagnostic and therapeutic purposes, supporting procedures like ESWL, ureteroscopy, and percutaneous nephrolithotomy (PCNL). Urologists rely on advanced imaging and laser systems to ensure accurate stone localization, effective fragmentation, and complete removal, improving patient outcomes and reducing recurrence rates. These devices are also critical in outpatient surgical centers, where minimally invasive procedures are often performed to treat smaller stones, allowing for same-day discharge and faster recovery.

In emergency care settings, handheld ultrasound devices and portable imaging tools are becoming essential for rapid diagnosis and assessment of acute urolithiasis cases, enabling quick decision-making for appropriate treatment. Telemedicine platforms are also integrating diagnostic capabilities with remote consultation for initial assessment and follow-up care, supporting broader access to urolithiasis management. In primary care and clinics, non-invasive diagnostic tools like ultrasound and advanced urine analysis kits are used to detect stone formation early, facilitating timely referral to specialists and reducing the need for emergency interventions. Additionally, in-home care settings, wearable sensors and digital health apps are being used to monitor hydration, dietary intake, and potential stone symptoms, helping patients manage urolithiasis proactively. As healthcare becomes more decentralized and patient-centric, the applications of urolithiasis management devices are expanding, reflecting their versatility in addressing diverse healthcare needs across different care settings.

What Drives Growth in the Urolithiasis Management Devices Market?

The growth in the Urolithiasis Management Devices market is driven by several factors, including the rising prevalence of kidney stones, increasing adoption of minimally invasive treatments, and advancements in diagnostic and therapeutic technologies. One of the primary growth drivers is the global rise in urolithiasis cases, fueled by lifestyle factors such as poor hydration, high-sodium diets, obesity, and metabolic conditions like diabetes and hypertension. As the incidence of kidney stones increases, the demand for effective and timely management solutions has surged, making urolithiasis management devices essential tools for healthcare providers. The growing awareness of minimally invasive procedures, such as ESWL, ureteroscopy, and laser lithotripsy, has further driven the adoption of these devices, as patients and providers prefer treatments that offer faster recovery, reduced pain, and lower complication rates.

Advancements in imaging and laser technologies have also played a significant role in the market’s growth. The development of high-definition digital ureteroscopes, advanced lithotripters, and AI-driven diagnostic tools has improved the accuracy, safety, and efficiency of kidney stone treatment, leading to better patient outcomes. Additionally, the integration of AI and machine learning in imaging and diagnostics is enhancing stone detection, characterization, and treatment planning, making urolithiasis management more precise and personalized. Government initiatives and healthcare policies that promote better urological care, increased healthcare access, and awareness campaigns about kidney stone prevention and management have further supported market growth.

The rise of outpatient surgical centers and ambulatory care facilities has also contributed to the growth of the urolithiasis management devices market. These settings offer cost-effective and efficient treatments, increasing patient access to minimally invasive procedures. The expansion of telehealth and digital health tools for remote monitoring, dietary guidance, and post-treatment care has made urolithiasis management more comprehensive, supporting patients in managing their condition proactively. As healthcare systems continue to prioritize patient-centered care and advanced medical technologies, the demand for urolithiasis management devices is expected to grow, driven by innovations in treatment, increasing healthcare awareness, and the global focus on improving urological outcomes.

SCOPE OF STUDY:

The report analyzes the Urolithiasis Management Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Other Treatment Types); End-Use (Hospitals & Clinics, Ambulatory Surgical Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Boston Scientific Corporation
  • Cook Medical, LLC
  • Dornier MedTech GmbH
  • Gimmi GmbH
  • KARL STORZ SE & Co. KG
  • Olympus America
  • Olympus Europa SE & Co. KG
  • Richard Wolf GmbH
  • Storz Medical AG
  • Walz Elektronik GmbH

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Urolithiasis Management Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Incidence of Kidney Stones Drives Demand for Urolithiasis Management Devices
    • Growing Preference for Non-Surgical Treatments Sets the Stage for Device Adoption
    • Integration of Laser Technologies in Treatment Drives Urolithiasis Device Market
    • Expanding Role of Extracorporeal Shock Wave Lithotripsy (ESWL) Boosts Market Demand
    • Increasing Adoption of Ultrasound Imaging Drives Urolithiasis Treatment Solutions
    • Push for Single-Use Devices to Prevent Infections Boosts Device Adoption
    • Case Overview: Growth in Urology Clinics Enhances Demand for Urolithiasis Devices
    • Growing Use of Robotics in Stone Management Sets the Stage for Device Adoption
    • Focus on Outpatient Stone Treatment Enhances Market Opportunities
    • Increasing Prevalence of Obesity Propels Urolithiasis Device Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Urolithiasis Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Urolithiasis Management Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Extracorporeal Shock Wave Lithotripsy (ESWL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Extracorporeal Shock Wave Lithotripsy (ESWL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Extracorporeal Shock Wave Lithotripsy (ESWL) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Intracorporeal Lithotripsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Intracorporeal Lithotripsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Intracorporeal Lithotripsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Percutaneous Nephrolithotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Urolithiasis Management Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Urolithiasis Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Urolithiasis Management Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Urolithiasis Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Urolithiasis Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Urolithiasis Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Urolithiasis Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Urolithiasis Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Urolithiasis Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030

IV. COMPETITION